This Selloff Looks Like August — Bill Baruch Stays Bullish but Wants Proof
Bill Baruch thinks the selloff got exacerbated — exploding put volume, leveraged ETF selling, and profit-taking after tech charts ran straight up to the right. He’s comparing it to August 2024’s sharp drop that became the low before the summer rally kicked in. But he’s not fully convinced yet: he needs to see healthcare and […]
CEO Abel Is Swinging — Bill Baruch Buys More Berkshire While Nobody’s Watching
Financials are at their lowest level relative to the S&P in history, and Bill Baruch is leaning in. He added to Berkshire Hathaway while the stock sits below its 200-day moving average and trades out of favor — but he sees the setup forming. New CEO Greg Abel is putting Berkshire’s mountain of cash to […]
The Name That Keeps Him Up at Night — Bill Baruch Trims Meta to At-Weight
Meta popped 7–8% in two days after rolling out a new AI agent for business — and Bill Baruch used that strength to trim. He’s moved from overweight to at-weight, and of all the megacaps he holds, Meta is the one that makes him uncomfortable. The AI spend is hard to trust, the stock is […]
The Tides are Turning for Services — Bill Baruch Bullish on ServiceNow
Bill Baruch is bullish on ServiceNow and sees the momentum building in the services space. This is one he wants exposure to right now. Watch the full discussion here.
Reading the Cycle — Bill Baruch Trims Amazon and Alphabet Ahead of June
Bill Baruch is taking some chips off the table in Amazon and Alphabet — and the timing is deliberate. His business cycle analysis signals cyclical highs coming in June, and with a potential pullback on the horizon, he’s trimming at the top to build cash for the second half of the year. Watch the full […]
Still Bullish, Just Being Smart — Bill Baruch Trims Nvidia
Bill Baruch trimmed Nvidia purely for portfolio management — NVDA remains his top position and the bullish conviction hasn’t budged. Watch the full discussion here.
Has Micron Euphoria Peaked? — Bill Baruch Trims
Micron was Bill Baruch’s largest position, until the euphoria got too loud to ignore. He trimmed nearly half near his $900 target and isn’t rushing back in. Watch the full discussion here.
Healthcare Shake‑Up: Time to Cut Thermo Fisher and Chase Lilly’s Momentum?
TMO’s slide killed the momentum, so Bill Baruch rotated out and into LLY’s breakout strength. He’s betting LLY earnings surge can fuel a run through June. Watch the full discussion here.
Buying the Bear Trap in Software
Friday’s breakdown turned into a bear trap, and Bill Baruch is buying. He began adding to MSFT NOW META and TSLA on Monday. Watch the full discussion here.
Does this Rally Have Legs?
The market has a bullish heartbeat and is back above the 200 dma, since the VIX hit 30 and Powell’s dovish comments. Bill Baruch explains why the trend still has legs, but higher expectations and key resistance levels are starting to matter more. Don’t miss the committee’s full discussion. Discover Blue Line Capital Ready to […]